Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zimmer Biomet Holdings ( (ZBH) ) has shared an update.
On October 7, 2025, Zimmer Biomet Holdings completed the acquisition of Monogram Technologies, an AI-driven orthopedic robotics company. This strategic move aims to expand Zimmer Biomet’s portfolio by integrating Monogram’s semi- and fully autonomous robotic technologies, enhancing their offerings in orthopedic procedures. The acquisition is expected to strengthen Zimmer Biomet’s position in the industry by providing surgeons with a broader choice of robotic and navigation solutions, thereby accelerating innovation and supporting long-term growth.
The most recent analyst rating on (ZBH) stock is a Hold with a $104.00 price target. To see the full list of analyst forecasts on Zimmer Biomet Holdings stock, see the ZBH Stock Forecast page.
Spark’s Take on ZBH Stock
According to Spark, TipRanks’ AI Analyst, ZBH is a Outperform.
Zimmer Biomet Holdings’ overall stock score of 73 reflects strong financial performance and positive earnings call guidance, offset by bearish technical indicators and moderate valuation. The company’s strategic acquisitions and new product launches are expected to drive future growth, but attention to improving net profit margins and overcoming international order delays will be crucial.
To see Spark’s full report on ZBH stock, click here.
More about Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a global leader in medical technology, specializing in orthopedic robotics and navigation technologies. The company offers a comprehensive portfolio designed to enhance mobility and improve health, leveraging data analytics and artificial intelligence across its suite of integrated digital and robotic solutions.
Average Trading Volume: 1,554,037
Technical Sentiment Signal: Sell
Current Market Cap: $19.58B
For detailed information about ZBH stock, go to TipRanks’ Stock Analysis page.